加味桂枝芍药知母汤联合西药治疗类风湿性关节炎临床观察被引量：4

下载PDF

导出

摘要目的:观察加味桂枝芍药知母汤联合西药治疗类风湿性关节炎的临床疗效.方法:选取类风湿性关节炎患者106例,按照随机数字表法将其分为两组,各53例.对照组行常规西药治疗,在此基础上观察组联合加味桂枝芍药知母汤治疗.观察两组疗效、生化指标及中医证候积分.结果:对照组总有效率低于观察组,差异有统计学意义(P<0.05);治疗后两组CRP、ESR、RF、中医证候积分较治疗前均降低,且观察组降低更加显著,差异有统计学意义(P<0.05).结论:加味桂枝芍药知母汤联合西药治疗可有效改善类风湿性关节炎患者临床症状及各项生化指标,提高治疗效果.

作者崔长锋

机构地区河南省正阳县中医院

出处《中国民族民间医药》 2019年第13期128-129,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy

关键词类风湿性关节炎加味桂枝芍药知母汤甲氨蝶呤中医证候积分

分类号 R259 [医药卫生—中西医结合]

引文网络
相关文献

参考文献7

1李晓晨,张杰.活动期类风湿关节炎的中医病机分析[J].环球中医药,2016,9(11):1412-1413. 被引量：21
2类风湿关节炎患者的慢病管理专家共识（2014版）[J].中华风湿病学杂志,2016,20(2):127-131. 被引量：96
3钱鑫,孙志岭,魏刚,郭云柯.自拟中药汤剂联合西药治疗类风湿关节炎临床疗效及安全性观察[J].辽宁中医杂志,2015,42(12):2371-2373. 被引量：16
4杨通宇,胡鲲,刘照时,李溥,陆耀宇,甘龙飞,胡建山.飞金止痛胶囊联合甲氨蝶呤和雷公藤多苷治疗类风湿关节炎的临床观察[J].中国药房,2016,27(23):3218-3220. 被引量：28
5李慧云,郭刚,李小佼,张海顺.针灸联合桂枝芍药知母汤及中药熏蒸治疗类风湿性关节炎临床研究[J].四川中医,2017,35(3):124-127. 被引量：31
6类风湿关节炎诊治指南[J].现代实用医学,2004,16(3):184-188. 被引量：93
7夏聪敏,许波,李刚,李嘉程,阎博昭,梁学振,骆帝.基于网络药理学探讨桂枝芍药知母汤治疗骨性关节炎的分子机制[J].中华中医药学刊,2018,36(11):2681-2684. 被引量：25

二级参考文献90

1姜泉,蒋红,曹炜,焦娟.475例类风湿关节炎患者中医临床证候分析[J].中医杂志,2007,48(3):253-255. 被引量：141
2王秋静,路航,吕文伟,刘芬,刘洁.飞龙掌血水提物镇痛抗炎作用的实验研究[J].中国实验方剂学杂志,2007,13(5):35-37. 被引量：27
3李瑞,孟庆刚.类风湿性关节炎的临床治疗研究[J].中华中医药学刊,2007,25(7):1348-1352. 被引量：35
4Takeuchi T,Harigai M,Tanaka Y,et al.Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treat-ment with disease-modifying antirheumatic drugs:results of the phase 2/3,multicentre,randomised,double-blind,placebo-controlled GO-MONO study through 24 weeks[J].Annals of the rheumatic diseases,2013,72(9):1488-1495.
5Lambert J,Hansen B B,Arnould B,et al.Linguistic Validation into 20Languages and Content Validity of the Rheumatoid Arthritis-Specific Work Productivity and Activity Impairment Questionnaire[J].The Patient-Patient-Centered Outcomes Research,2014,7(2):171-176.
6Ossipova E,Oliynyk G,Cerqueira C,et al.A10.14 Identification ofNovel ACPA Targets in Rheumatoid Arthritis Synovial Tissues Using2D Gel Electrophoresis and Mass Spectrometry[J].Annals of the Rheumatic Diseases,2013,72(Suppl1):A77.
7Dougados M, Soubrier M, Perrodeau E, et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, muhicentre, ran- domised, controlled trial (COMEDRA) [J]. Ann Rheum Dis, 2015, 74: 1725-1733. DOI: 10.1136/annrheumdis-2013-204733.
8Van den Hout WB, Tijhuis GJ, Hazes JM, et al. Cost effec- tiveness and cost utility analysis of muhidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care [J]. Ann Rheum Dis 2003, 62 ( 4 ) : 308-315. DOI : 10.1136/ard.62.4.308.
9Dougados M, Betteridge N, Burmester GR, et al. EULAR standardised operating procedures for the elaboration, evalua- tion, dissemination, and implementation of recommendations endorsed by the EULAR standing committees[J]. Ann Rheum Dis, 2004, 63(9): 1172-1176. DOI: 10.1136/ard.2004.023697.
10van Eijk-Hustings Y, van Tubergen A, Bostrm C, et al. EULAR recommendations for the role of the nurse in the manage- ment of chronic inflammatory arthritis[J]. Ann Rheum Dis, 2012, 71 ( 1 ) : 13-19. DOI: lO.1016/annrheumdis-2011-200185.